The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.30
Ask: 9.50
Change: -0.35 (-3.59%)
Spread: 0.20 (2.151%)
Open: 9.55
High: 10.00
Low: 9.50
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Mon, 29th Mar 2021 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Appoints Rain Newton-Smith as independent non-executive director, starting May 11. Newton-Smith will replace Roger Bone, who is retiring. She is chief economist at the Confederation of British Industry. Previous to the CBI, she was head of Emerging Markets at Oxford Economics. FTSE 250-listed F&C Investment Trust bills itself as the world's oldest collective investment scheme, having launched in 1868.

----------

Spirent Communications PLC - Crawley, England-based provider of testing, analytics and security for telecommunications networks - Appoints Maggie Buggie as non-executive director with effect on April 29. Buggie is currently chief business offer at SAP Services, which is part of Walldorf, Germany-based enterprise software developer SAP SE.

----------

Vesuvius PLC - London-based molten metal flow engineering - Hires Dinggui Gao as non-executive director, starting on Thursday. He currently is managing director of China for Formel D Group, a German service provider to the automotive and components supply industry.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery - Hires Karl Keegan as chief financial officer, effective immediately. Keegan was most recently chief executive officer of privately held Hox Therapeutics Ltd.

----------

Okyo Pharma Ltd - London-based biotechnology company focused on treatments of inflammatory dry eye diseases and ocular pain - Hires Rajkumar Patil as chief scientific officer. Says Patil has 30 years of ophthalmic and pharmaceutical research and development experience, including with Ora Inc and iVeena Delivery Systems. He also worked at the Alcon/Novartis Institute of Biomedical Research.

----------

Serinus Energy PLC - oil and gas exploration and production in Tunisia and Romania - Dawid Jakubowicz resigns immediately from board, while Eleanor Barke won't stand for re-election to the board at the May 13 annual general meeting. In their place, Serinus hires Natalie Fortescue and Jon Kempster. Fortescue was an investment banker at Investec and Oriel Securities. She joined Genel Energy PLC to establish the investor relations department and also worked with Premier Oil PLC on its reverse takeover by Chrysaor Energy Ltd. Kempster has held CFO positions at companies including London listings Frasers Group PLC and Wincanton PLC, and he currently is interim CFO of FireAngel Safety Technology Group PLC. Kempster also currently is a non-executive director of Bonhill Group PLC, Redcentric PLC and Ted Baker PLC.

----------

Fragrant Prosperity Holdings Ltd - seeking acquisition in cannabis therapeutics - Hires Daniel Reshef as non-executive director starting on Wednesday. Reshef has had a 25-year career in drug development, including with Hoffman La Roche, Genentech and Bristol Myers Squibb Co.

----------

French Connection Group PLC - London-based fashion retailer - Hires Neil Page as independent non-executive director. Page was CFO of retailer Carpetright PLC. French Connection entered a formal sales process at the beginning of month after receiving two separate takeover approaches.

----------

Braveheart Investment Group PLC - makes strategic investments in companies it thinks will outperform - Jonathan Freeman steps down as non-executive director "to devote more time to his other business interests". Starts process for finding a new non-executive director.

----------

Arix Bioscience PLC - venture capital investor in biotech companies - Pauses hire of James Noble and Axel Wieandt as non-executive directors, citing recently announced strategic review, which encompasses board composition.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.